The 5th ReSViNET Foundation Conference RSVVW 2019, a global conference on novel RSV therapeutics will be held on 12-14 November 2019, in the beautiful capital city of Ghana, Accra. The main goal of this conference is to offer a platform where the RSV community can share and discuss the latest research focusing on prevention as well as treatment of RSV infection. It aims to bring together stakeholders involved in RSV research such as scientists, physicians, pharmaceutical companies, and representatives from FDA, PATH, WHO, EMA, NIH, and BMGF.
Researchers and physicians from around the world are invited to join the discussion and share their knowledge. Specifically, scientists and physicians from low- and middle-income countries andyoung researchers are encouraged to attend, and may apply with the organizers to receive support.
A diverse program is being developed by the Scientific Advisory Committee, Our IMPRINT network PI Beate Kampmann being part of it, which will include: burden of RSV disease and mortality, molecular virology, immunology, prevention and treatment developments, global health perspectives and RSV-related sequelae. For more details on travel funds and latest updates, please visit the website (www.resvinet.org).
A new publication by Chris Gale, Maria A Quigley, Anna Placzek et al. portrays characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK.